Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/1989
11/15/1989EP0341444A2 Rapid mutational analysis method
11/15/1989EP0341304A1 Improved ricin molecules and ricin toxin conjugates
11/15/1989EP0341303A1 Monoclonal antibody against the rgd-directed adhesion receptor of endothelial cells
11/15/1989EP0341290A1 Immunoglobulin e competitor
11/15/1989EP0341287A1 Diagnostic methods and systems for quantifying apo ai
11/15/1989EP0341273A1 Biological materials, processes for producing biological materials and for using such materials in therapy
11/15/1989EP0341252A1 Human polymorphic epithelial mucin polypeptides for use in therapy and diagnosis
11/15/1989EP0335528A2 DNA promoter fragments from wheat
11/15/1989EP0165313B1 Nucleic acid hybridization assay
11/15/1989CN1037174A Novel revombinant and chimeric antibodies directed against human adenocarcinoma
11/15/1989CN1037173A Bone inducing protein
11/14/1989US4880915 Tumor necrosis factor; dye ligand covalently bound to crosslinked agarose
11/14/1989US4880911 Urogastrone, interferons
11/14/1989US4880910 Polypeptides, milk production
11/14/1989US4880746 Vectors, dna
11/14/1989US4880744 Acidic medium, rice
11/14/1989US4880741 Dna, marking
11/14/1989US4880734 Eukaryotic regulatable transcription
11/14/1989CA1262877A1 Expression vector of factor ix and cell line producing the active factor ix
11/14/1989CA1262863A1 Fusogenic liposomes and method of making same
11/08/1989EP0341215A2 Improvements in the production of polypeptides
11/08/1989EP0341100A2 DNA coding for thymosin and TNF
11/08/1989EP0340986A2 High level expression of proteins in yeast
11/08/1989EP0340948A1 Novel hybrid pesticidal toxins
11/08/1989EP0340837A1 Recombinant GAG precursor of HIV, product, process, and use as aids vaccine
11/08/1989EP0340806A2 Synthesis of human virus antigens by yeast
11/08/1989EP0340805A1 Superoxide dismutase and expression in microorganisms
11/08/1989EP0340609A2 Device for the isolation of nucleic acids
11/08/1989EP0340359A1 Baculovirus transfer vectors
11/08/1989EP0340333A2 Novel physiologically active polypeptide and pharmaceutical composition
11/08/1989CN1036987A Human c3b/c4b receptor (cr1)
11/07/1989US4879374 Genetic vectors, genetic engineering
11/07/1989US4879241 Cloning vectors, genetic engineering
11/07/1989US4879236 Genetic engineering, baculovirus
11/07/1989US4879231 Transformation of yeasts of the genus pichia
11/07/1989US4879230 Escherichia coli Candida maltosa Saccharomyces cerevisiae shuttle vectors and method for making
11/07/1989US4879227 Gene expression of protein
11/07/1989US4879226 Novel human physiologically active polypeptide
11/07/1989US4879225 Enhanced production of antibodies utilizing insolubilized immune complexes
11/07/1989US4879224 DNA sequences, recombinant DNA molecules and processes for producing human phospholipase inhibitor polypeptides
11/07/1989US4879219 Immunoassay utilizing monoclonal high affinity IgM antibodies
11/07/1989US4879217 Monoclonal antibodies for immunoassay
11/07/1989EP0270615A4 TRANSFORMATION AND FOREIGN GENE EXPRESSION IN -i(BRASSICA) SPECIES.
11/07/1989CA1262799A1 Broad spectrum vaccine against gonorrhea
11/07/1989CA1262696A1 Process for the microbiological preparation of the human serum-albumin
11/07/1989CA1262695A1 Process for the microbiological preparation of the human serum-albumin
11/07/1989CA1262694A1 Method of improving the yield of heterologous protein produced by cultivating recombinant bacteria
11/02/1989WO1989010565A1 Detection, quantitation and classification of ras proteins in body fluids and tissues
11/02/1989WO1989010413A1 Replicatable hybridizable recombinant rna probes and methods of using same
11/02/1989WO1989010412A1 Detection of neu gene expression and products
11/02/1989WO1989010409A1 Bone and cartilage inductive compositions
11/02/1989WO1989010408A1 Method of obtaining l-alanine
11/02/1989WO1989010407A1 Homogeneous dimeric m-csf and storage stable formulations thereof
11/02/1989WO1989010406A1 Bovine placental lactogen gene
11/02/1989WO1989010405A1 Chimeric glycoproteins containig immunogenic segments of human parainfluenza virus type 3
11/02/1989WO1989010404A1 Recombinant dna methods, vectors and host cells
11/02/1989WO1989010403A1 Human gm-csf variants
11/02/1989WO1989010402A1 Low molecular weight derivatives of prourokinase and pharmaceutical compositions containing the same
11/02/1989WO1989010401A1 Plasminogene activators with increased fibrin selectivity
11/02/1989WO1989010396A1 Plants with modified stamen cells
11/02/1989WO1989010376A1 Monoclonal antibody for colorectal carcinoma
11/02/1989WO1989010375A1 Monoclonal antibodies specific for the harvey, kirsten and n ras proteins and their use as diagnostic reagents
11/02/1989WO1989010374A1 Aprotinin analogues and a process for the production thereof
11/02/1989WO1989010137A1 Vaccine derived from bacteria of the genus yersinia
11/02/1989WO1989010133A1 Stem cell inhibitors
11/02/1989WO1989007651A3 Methods for controlling norleucine content in polypeptides
11/02/1989EP0340197A2 Insect-resistant lettuce plants
11/02/1989EP0340170A2 Process for the production of polypeptides
11/02/1989EP0340109A2 Anti-T-cell receptor determinants as autoimmune disease treatment
11/02/1989EP0339942A2 Aprotinin analogues and process for the production thereof
11/02/1989EP0339830A2 Improved biological nitrogen fixation
11/02/1989EP0339814A1 Reagent for measuring creatine kinase activity and measuring method thereof
11/02/1989EP0339783A2 Detection of yersinia enterocolitica using nucleic acid probes
11/02/1989EP0339686A1 Nucleic acid hybridization assay
11/02/1989EP0339633A2 Anti-human gastric cancer monoclonal antibody
11/02/1989EP0339632A2 Method of assaying human cancer antigens
11/02/1989EP0339569A2 Expression of the HIV 24 KDA GAG protein in methylotrophic yeasts
11/02/1989EP0339567A1 Expression of Hepatitis B PreS 2 Protein in Methylotrophic Yeasts
11/02/1989EP0339532A1 DNA strand coding for alpha-acetolactate decarboxylase and yeast transformed with the DNA strand
11/02/1989EP0339443A2 Monoclonal antibody for the selective immune determination of intact procollagen peptide (type III) and procollagen (type III) in body fluids
11/02/1989EP0339389A1 Test device
11/02/1989EP0339285A2 Recombinant endonexin II
11/02/1989EP0339163A2 Monoclonal antibodies specific for HIV and hybridomas for their production
11/02/1989DE3909249A1 DNA with genetic information of glutamine synthetase and use thereof
11/02/1989DE3744038A1 Human manganese superoxide dismutase (hMn-SOD)
11/01/1989CN1036793A Monoclonal antibody specific to mucin-like glycoprotein surface antigen on human carcinoma cells
10/1989
10/31/1989US4877865 Bovine interferon
10/31/1989US4877864 Osteoinductive factors
10/31/1989US4877737 Attenuated pseudorabies virus which has a deletion in at least a portion of a repeat sequence and vaccine containing same
10/31/1989CA1262533A1 High level production of swine growth hormone
10/31/1989CA1262532A1 Composition useful for the production of vaccines containing particles with the surface antigen of the hepatitis b virus and the receptor of the polymerized human serum albumin, animal cells capable of producing such particles and process for their obtention
10/25/1989EP0339009A2 Method for improving the efficacy of insect toxins
10/25/1989EP0338841A1 Recombinant DNA methods, vectors and host cells
10/25/1989EP0338807A2 Production of isolated proteinaceous materials using recombinant avipox virus vectors
10/25/1989EP0338790A2 Production of homoserine and its derivatives such as threonine derivatives and methionine precursors
10/25/1989EP0338767A2 Novel recombinant and chimeric antibodies directed against a human adenocarcinoma antigen
10/25/1989EP0338745A1 Method for producing recombinant DNA proteins
10/25/1989EP0338690A1 Regulation of gene expression
10/25/1989EP0338634A2 Viper venom polypeptides and genetic expression
10/25/1989EP0338620A1 Recovery of hepatitis B surface antigen